Bloomberg reports the obesity drug market is expected to reach as much as $130 billion in annual sales by 2030.

While some drugs have fallen off, more have been added: AbbVie recently jumped into the obesity craze by licensing an ...

Use of GLP-1 receptor agonists for obesity was associated with a reduced risk of primary open-angle glaucoma (POAG) and ...

The European makers of Ozempic for diabetes and Cetaphil for dry skin said they would feel an impact from President Donald ...

AbbVie Inc. ( NYSE: ABBV) TD Cowen 45th Annual Health Care Conference March 5, 2025 9:10 AM ET Scott T. Reents - Executive Vice President and Chief Financial Officer Jeffrey R. Stewart - Executive ...

In recognition of World Obesity Day,�Ivim Health is proud to advocate on behalf of patients on their health journeys by providing personalized and effective care, guided by medical professionals who ...

The study, published in the Journal of Pediatrics, was written by Goyal as lead author, in collaboration with researchers ...